DESCOVY (emtricitabine and tenofovir alafenamide) tablets

DESCOVY is a brand-name prescription drug that’s FDA-approved to treat HIV-1 infection . Brand Name: DESCOVY (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015

Home | (emtricitabine and tenofovir alafenamide) tablets

DESCOVY (emtricitabine and tenofovir alafenamide) tablets Price In India and Overseas
DESCOVY (emtricitabine and tenofovir alafenamide) tablets

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Overseas Patient/ Export inquires.

Call / WhatsApp Number
+91 9643240915 (Mr. Yashpal Singh)
+91 9289711087 (Ms. Sana Sadyar)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

DESCOVY (emtricitabine and tenofovir alafenamide) tablets

Emtricitabine and tenofovir alafenamide combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection.

DESCOVY is a prescription medicine that may be used in two different ways. DESCOVY is used:
• to treat HIV-1 infection
• for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (35 kg). It is not known if DESCOVY is effective in reducing the risk of getting HIV-1 from certain types of sex.

Emtricitabine and tenofovir alafenamide combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection. Your doctor may do tests to make sure you are negative from HIV-1 infection before taking this medicine for HIV-1 PrEP.

Drug (Brand / Generic): DESCOVY / emtricitabine and tenofovir alafenamide tablets
Current Indications: HIV-1 infection
Marketed by:: Gilead Sciences, Inc
Approval Date: 2015

Available as (Form & Strength): Tablets: 200 mg of FTC and 25 mg of TAF

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.